TrialClinical pharmacology in drug development2026

Results of a Phase 1 Study Assessing the Effect of CIN-102, a Novel Formulation of the Dopamine Receptor Antagonist Domperidone Designed to Treat Gastroparesis, on Cardiac Repolarization in Healthy Volunteers.

Mary Bond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.